RESECTABLE DEDIFFERENTIATED LIPOSARCOMA
Clinical trials for RESECTABLE DEDIFFERENTIATED LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE DEDIFFERENTIATED LIPOSARCOMA trials appear
Sign up with your email to follow new studies for RESECTABLE DEDIFFERENTIATED LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise against rare sarcomas before surgery
Disease control OngoingThis study tests whether giving immunotherapy drugs (nivolumab with or without ipilimumab) and radiation before surgery can help shrink tumors in people with two rare types of sarcoma. About 32 adults with these sarcomas that can be surgically removed will receive the treatment a…
Matched conditions: RESECTABLE DEDIFFERENTIATED LIPOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 22:50 UTC
-
Immunotherapy duo shows promise in early sarcoma trial
Disease control OngoingThis early-phase study tests whether adding an experimental drug called BO-112 to the immunotherapy nivolumab is safe and effective for people with soft tissue sarcoma that can be surgically removed. About 14 participants will receive the combination before surgery. The main goal…
Matched conditions: RESECTABLE DEDIFFERENTIATED LIPOSARCOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC